These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31666360)

  • 1. Viral Load Measurements in Individuals with Hepatitis C Virus Infection: on the European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C 2018.
    Rando-Segura A; Buti M; Quer J; López-Martínez R; Rodríguez-Frías F
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666360
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
    Moorman AC; Xing J; Rupp LB; Gordon SC; Spradling PR; Boscarino JA; Schmidt MA; Daida YG; Teshale EH; Holmberg SD;
    Gastroenterology; 2018 Feb; 154(3):754-758. PubMed ID: 29360428
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 4. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.
    Grebely J; Matthews GV; Petoumenos K; Dore GJ
    J Viral Hepat; 2010 Dec; 17(12):896. PubMed ID: 20051007
    [No Abstract]   [Full Text] [Related]  

  • 6. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus.
    Pérez-García A; Aguinaga A; Navascués A; Castilla J; Ezpeleta C
    Int J Infect Dis; 2019 Dec; 89():131-136. PubMed ID: 31580940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C: Treatment triumphs.
    Rice CM; Saeed M
    Nature; 2014 Jun; 510(7503):43-4. PubMed ID: 24899301
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of novel treatments for hepatitis C.
    Webster DP; Klenerman P; Collier J; Jeffery KJ
    Lancet Infect Dis; 2009 Feb; 9(2):108-17. PubMed ID: 19179226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.
    Leblebicioglu H; Arends JE; Ozaras R; Corti G; Santos L; Boesecke C; Ustianowski A; Duberg AS; Ruta S; Salkic NN; Husa P; Lazarevic I; Pineda JA; Pshenichnaya NY; Tsertswadze T; Matičič M; Puca E; Abuova G; Gervain J; Bayramli R; Ahmeti S; Koulentaki M; Kilani B; Vince A; Negro F; Sunbul M; Salmon D;
    Antiviral Res; 2018 Feb; 150():9-14. PubMed ID: 29217468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.
    Teegen EM; Globke B; Schott E; Pratschke J; Eurich D
    Exp Clin Transplant; 2018 Feb; 16(1):61-67. PubMed ID: 29137590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
    Soriano V; Tefferi A
    Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060
    [No Abstract]   [Full Text] [Related]  

  • 14. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
    Omata M; Kanda T; Wei L; Yu ML; Chuang WL; Ibrahim A; Lesmana CR; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Dokmeci AK; Al-Mahtab M; McCaughan GW; Wasim J; Crawford DH; Kao JH; Yokosuka O; Lau GK; Sarin SK
    Hepatol Int; 2016 Sep; 10(5):681-701. PubMed ID: 27229718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy.
    Sidharthan S; Kohli A; Sims Z; Nelson A; Osinusi A; Masur H; Kottilil S
    Clin Infect Dis; 2015 Jun; 60(12):1743-51. PubMed ID: 25733369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prisons, prisoners, and hepatitis C.
    Ferguson L; Batey R
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
    [No Abstract]   [Full Text] [Related]  

  • 18. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Yanny B; Saab S; Durazo F; Latt N; Mitry A; Mikhail MM; Hanna RM; Aziz A; Sahota A
    Dig Dis Sci; 2018 Dec; 63(12):3480-3486. PubMed ID: 30259281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma.
    Rodríguez-García A; Linares M; Morales ML; Allain-Maillet S; Mennesson N; Sanchez R; Alonso R; Leivas A; Pérez-Rivilla A; Bigot-Corbel E; Hermouet S; Martínez-López J
    Front Immunol; 2021; 12():797209. PubMed ID: 35087522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLA2R related primary membranous nephropathy in a hepatitis C positive patient.
    Ramachandran R; Yadav AK; Kumar V; Varma A; Taneja S; Nada R; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Mar; 23(3):288. PubMed ID: 29460999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.